» Articles » PMID: 7610770

A New Form of Ovine GM1-gangliosidosis

Overview
Specialty Neurology
Date 1995 Jan 1
PMID 7610770
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Neurological signs were observed in 3 lambs at approximately 1 month of age, in a flock of 1 ram and 29 ewes with 43 lambs. Deterioration occurred such that the lambs had either died or been killed by 4 months of age. Necropsies of two of these lambs revealed a diffuse encephalopathy in which the most prominent feature was ballooned neurons. Sections of frozen brain showed PAS-positive, oil red O-negative, and weak Sudan Black-positive material in the swollen neuronal cytoplasm. The ultrastructure of the neuronal inclusions showed characteristic whorled membranes, suggesting diagnosis of a gangliosidosis. The underlying enzymic defect was investigated by assaying 11 lysosomal enzymes in extracts of kidney from an affected lamb and from normal lambs. A deficiency (90%) of acidic beta-D-galactosidase was found in the affected lamb. All other activities, including N-acetylneuraminidase, were normal. A specific deficiency of lysosomal beta-D-galactosidase was demonstrated by separating the lysosomal and cytosolic beta-D-galactosidase by chromatography on concanavalin A-Sepharose. Diagnosis of GM1-gangliosidosis, analogous to the severe infantile form of the human disease, was made on the basis of the pathology and enzymology. The beta-D-galactosidase activity in the white blood cells of the ram and several of the ewes was consistent with their being heterozygotes. This disorder is different from a previously described lipidosis in sheep, in which there was a combined deficiency of beta-D-galactosidase and alpha-neuraminidase.

Citing Articles

Axonopathy and Reduction of Membrane Resistance: Key Features in a New Murine Model of Human G-Gangliosidosis.

Eikelberg D, Lehmbecker A, Brogden G, Tongtako W, Hahn K, Habierski A J Clin Med. 2020; 9(4).

PMID: 32252429 PMC: 7230899. DOI: 10.3390/jcm9041004.


Human knockout cerebral organoids: A model system for testing AAV9-mediated gene therapy for reducing GM1 ganglioside storage in GM1 gangliosidosis.

Latour Y, Yoon R, Thomas S, Grant C, Li C, Sena-Esteves M Mol Genet Metab Rep. 2019; 21:100513.

PMID: 31534909 PMC: 6744524. DOI: 10.1016/j.ymgmr.2019.100513.


In situ detection of GM1 and GM2 gangliosides using immunohistochemical and immunofluorescent techniques for auxiliary diagnosis of canine and feline gangliosidoses.

Kohyama M, Yabuki A, Ochiai K, Nakamoto Y, Uchida K, Hasegawa D BMC Vet Res. 2016; 12:67.

PMID: 27036194 PMC: 4815186. DOI: 10.1186/s12917-016-0691-y.


Molecular consequences of the pathogenic mutation in feline GM1 gangliosidosis.

Martin D, Rigat B, Foureman P, Varadarajan G, Hwang M, Krum B Mol Genet Metab. 2008; 94(2):212-21.

PMID: 18353697 PMC: 2910747. DOI: 10.1016/j.ymgme.2008.02.004.

References
1.
Murnane R, Prieur D, Ahern-Rindell A, Parish S, Collier L . The lesions of an ovine lysosomal storage disease. Initial characterization. Am J Pathol. 1989; 134(2):263-70. PMC: 1879591. View

2.
Healy P, Farrow B, Nicholas F, Hedberg K, Ratcliffe R . Canine fucosidosis: a biochemical and genetic investigation. Res Vet Sci. 1984; 36(3):354-9. View

3.
LANDING B, SILVERMAN F, Craig J, JACOBY M, LAHEY M, Chadwick D . FAMILIAL NEUROVISCERAL LIPIDOSIS. AN ANALYSIS OF EIGHT CASES OF A SYNDROME PREVIOUSLY REPORTED AS "HURLER-VARIANT," "PSEUDO-HURLER," AND "TAY-SACHS DISEASE WITH VISCERAL INVOLVEMENT". Am J Dis Child. 1964; 108:503-22. View

4.
Barker C, Blakemore W, Dell A, Palmer A, TILLER P, Winchester B . GM1 gangliosidosis (type 1) in a cat. Biochem J. 1986; 235(1):151-8. PMC: 1146662. DOI: 10.1042/bj2350151. View

5.
Read D, Harrington D, Keenana T, HINSMAN E . Neuronal-visceral GM1 gangliosidosis in a dog with beta-galactosidase deficiency. Science. 1976; 194(4263):442-5. DOI: 10.1126/science.824730. View